Design and optimization of piperlongumine analogs as potent senolytics

Xuan Zhang; Yonghan He; Xingui Liu; Xin Zhang; Peizhong Shi; Yingying Wang; Daohong Zhou; Guangrong Zheng

doi:10.1016/j.bmcl.2023.129593

Design and optimization of piperlongumine analogs as potent senolytics

Xuan Zhang, Yonghan He, Xingui Liu, Xin Zhang, Peizhong Shi, Yingying Wang, Daohong Zhou, Guangrong Zheng

Producción científica: Article › revisión exhaustiva

1 Cita (Scopus)

Resumen

Selective removal of senescent cells (SnCs) offers a promising therapeutic strategy to treat chronic and age-related diseases. Our prior investigations led to the discovery of piperlongumine (PL) and its derivatives as senolytic agents. In this study, our medicinal chemistry campaign on both the α,β-unsaturated δ-valerolactam ring and the phenyl ring of PL culminated in the identification of compound 24, which exhibited an impressive 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL.

Idioma original	English (US)
Número de artículo	129593
Publicación	Bioorganic and Medicinal Chemistry Letters
Volumen	98
DOI	https://doi.org/10.1016/j.bmcl.2023.129593
Estado	Published - ene 15 2024

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Acceder al documento

10.1016/j.bmcl.2023.129593

Otros archivos y enlaces

Citar esto

@article{7e7f360a18944dd5aa580dc8d99b5889,

title = "Design and optimization of piperlongumine analogs as potent senolytics",

abstract = "Selective removal of senescent cells (SnCs) offers a promising therapeutic strategy to treat chronic and age-related diseases. Our prior investigations led to the discovery of piperlongumine (PL) and its derivatives as senolytic agents. In this study, our medicinal chemistry campaign on both the α,β-unsaturated δ-valerolactam ring and the phenyl ring of PL culminated in the identification of compound 24, which exhibited an impressive 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL.",

keywords = "Cellular senescence, Piperlongumine, Senescent cells, Senolytics, Structure activity relationship",

author = "Xuan Zhang and Yonghan He and Xingui Liu and Xin Zhang and Peizhong Shi and Yingying Wang and Daohong Zhou and Guangrong Zheng",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Ltd",

year = "2024",

month = jan,

day = "15",

doi = "10.1016/j.bmcl.2023.129593",

language = "English (US)",

volume = "98",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Design and optimization of piperlongumine analogs as potent senolytics

AU - Zhang, Xuan

AU - He, Yonghan

AU - Liu, Xingui

AU - Zhang, Xin

AU - Shi, Peizhong

AU - Wang, Yingying

AU - Zhou, Daohong

AU - Zheng, Guangrong

PY - 2024/1/15

Y1 - 2024/1/15

N2 - Selective removal of senescent cells (SnCs) offers a promising therapeutic strategy to treat chronic and age-related diseases. Our prior investigations led to the discovery of piperlongumine (PL) and its derivatives as senolytic agents. In this study, our medicinal chemistry campaign on both the α,β-unsaturated δ-valerolactam ring and the phenyl ring of PL culminated in the identification of compound 24, which exhibited an impressive 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL.

AB - Selective removal of senescent cells (SnCs) offers a promising therapeutic strategy to treat chronic and age-related diseases. Our prior investigations led to the discovery of piperlongumine (PL) and its derivatives as senolytic agents. In this study, our medicinal chemistry campaign on both the α,β-unsaturated δ-valerolactam ring and the phenyl ring of PL culminated in the identification of compound 24, which exhibited an impressive 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL.

KW - Cellular senescence

KW - Piperlongumine

KW - Senescent cells

KW - Senolytics

KW - Structure activity relationship

UR - http://www.scopus.com/inward/record.url?scp=85180578799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180578799&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2023.129593

DO - 10.1016/j.bmcl.2023.129593

M3 - Article

C2 - 38104906

AN - SCOPUS:85180578799

SN - 0960-894X

VL - 98

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

M1 - 129593

ER -

Design and optimization of piperlongumine analogs as potent senolytics

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto